# Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections

> **NCT02951351** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 36 (actual)

## Conditions studied

- Age-related Macular Degeneration
- Diabetic Macular Edema
- Injection Site
- Injection Site Infection
- Pain, Postoperative

## Interventions

- **DRUG:** Proparacaine
- **PROCEDURE:** Conjunctival culture

## Key facts

- **NCT ID:** NCT02951351
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-12
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-04-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951351, "Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02951351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*